|
1
|
Moss JW, Davies TS, Garaiova I, Plummer
SF, Michael DR and Ramji DP: A Unique combination of nutritionally
active ingredients can prevent several key processes associated
with atherosclerosis in vitro. PLoS One. 11:e01510572016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Narasimhulu C Aluganti, Fernandez-Ruiz I,
Selvarajan K, Jiang X, Sengupta B, Riad A and Parthasarathy S:
Atherosclerosis-do we know enough already to prevent it? Curr Opin
Pharmacol. 27:92–102. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Conti P and Shaik-Dasthagirisaeb Y:
Atherosclerosis: A chronic inflammatory disease mediated by mast
cells. Cent Eur J Immunol. 40:380–386. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rojas J, Salazar J, Martínez MS, Palmar J,
Bautista J, Chávez-Castillo M, Gómez A and Bermúdez V: Macrophage
heterogeneity and plasticity: Impact of macrophage biomarkers on
atherosclerosis. Scientifica (Cairo). 2015:8512522015.PubMed/NCBI
|
|
5
|
Glass CK and Witztum JL: Atherosclerosis:
The road ahead. Cell. 104:503–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bogachev O, Majdalawieh A, Pan X, Zhang L
and Ro HS: Adipocyte enhancer-binding protein 1 (AEBP1) (a novel
macrophage proinflammatory mediator) overexpression promotes and
ablation attenuates atherosclerosis in ApoE (−/−) and LDLR (−/−)
mice. Mol Med. 17:1056–1064. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Q, Mei Y, Shoji T, Han X, Kaminski K,
Oh GT, Ongusaha PP, Zhang K, Schmitt H, Moser M, et al:
Rho-associated coiled-coil-containing kinase 2 deficiency in bone
marrow-derived cells leads to increased cholesterol efflux and
decreased atherosclerosis. Circulation. 126:2236–2247. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa
V, Dempsey C, Caunt JC, Oxley KM, Wyllie DH, Polgar T, Harte M, et
al: Human tribbles, a protein family controlling mitogen-activated
protein kinase cascades. J Biol Chem. 279:42703–42708. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Burkhardt R, Toh SA, Lagor WR, Birkeland
A, Levin M, Li X, Robblee M, Fedorov VD, Yamamoto M, Satoh T, et
al: Trib1 is a lipid- and myocardial infarction-associated gene
that regulates hepatic lipogenesis and VLDL production in mice. J
Clin Invest. 120:4410–4414. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Satoh T, Kidoya H, Naito H, Yamamoto M,
Takemura N, Nakagawa K, Yoshioka Y, Morii E, Takakura N, Takeuchi O
and Akira S: Critical role of Trib1 in differentiation of
tissue-resident M2-like macrophages. Nature. 495:524–528. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kathiresan S, Melander O, Guiducci C,
Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF,
Havulinna AS, et al: Six new loci associated with blood low-density
lipoprotein cholesterol, high-density lipoprotein cholesterol or
triglycerides in humans. Nat Genet. 40:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Willer CJ, Sanna S, Jackson AU, Scuteri A,
Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS,
Stringham HM, et al: Newly identified loci that influence lipid
concentrations and risk of coronary artery disease. Nat Genet.
40:161–169. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Glass CK and Saijo K: Nuclear receptor
transrepression pathways that regulate inflammation in macrophages
and T cells. Nat Rev Immunol. 10:365–376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Villacorta L, Schopfer FJ, Zhang J,
Freeman BA and Chen YE: PPARgamma and its ligands: Therapeutic
implications in cardiovascular disease. Clin Sci (Lond).
116:205–218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bouhlel MA, Staels B and Chinetti-Gbaguidi
G: Peroxisome proliferator-activated receptors-from active
regulators of macrophage biology to pharmacological targets in the
treatment of cardiovascular disease. J Intern Med. 263:28–42.
2008.PubMed/NCBI
|
|
17
|
Huang C: Natural modulators of liver X
receptors. J Integr Med. 12:76–85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zelcer N and Tontonoz P: Liver X receptors
as integrators of metabolic and inflammatory signaling. J Clin
Invest. 116:607–614. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bujold K, Rhainds D, Jossart C, Febbraio
M, Marleau S and Ong H: CD36-mediated cholesterol efflux is
associated with PPARgamma activation via a MAPK-dependent COX-2
pathway in macrophages. Cardiovasc Res. 83:457–464. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Majdalawieh AF and Ro HS: The
anti-atherogenic properties of sesamin are mediated via improved
macrophage cholesterol efflux through PPARγ1-LXRα and MAPK
signaling. Int J Vitam Nutr Res. 84:79–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yokoyama T, Kanno Y, Yamazaki Y, Takahara
T, Miyata S and Nakamura T: Trib1 links the MEK1/ERK pathway in
myeloid leukemogenesis. Blood. 116:2768–2775. 2010. View Article : Google Scholar : PubMed/NCBI
|
